Clinical Trials Directory

Trials / Completed

CompletedNCT00941161

Effect of Oral Combination Therapy in a Single Dosage Form in Patients With Type 2 Diabetes Mellitus

Effect of Oral Combination Therapy of Metformin Extended Release Over Glimepiride in a Single Dosage Form in Patients With Type 2 Diabetes Mellitus With Failure of Monotherapy

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
28 (estimated)
Sponsor
Laboratorios Silanes S.A. de C.V. · Industry
Sex
All
Age
40 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is to determinate the effect of combined oral therapy of long acting metformin/glimepiride in a single dose in patients with type 2 diabetes mellitus and monotherapy failure.

Detailed description

A randomized double-blind clinical trial, to determine the effect of combined therapy of oral prolonged-release metformin/glimepiride in a single dosage form on fasting glucose and HbA1c. Patients will be included in this study are patients with diabetes mellitus and secondary failure to monotherapy. Will also assess the effect of combined therapy on the oral lipid profile (total cholesterol, LDL, HDL, VLDL, Triglycerides) and on the sensitivity and insulin secretion. We evaluate the clinical measurements, laboratory and safety during 3 months, through the allocation of subjects to three study groups (metformin, glimepiride and metformin extended release / glimepiride)

Conditions

Interventions

TypeNameDescription
DRUGmetformin/glimepiride combinationlong acting metformin/glimepiride 1g/2mg
DRUGmetforminlong acting metformin 1g once a day with fasting glucose 130-199mg/dL or long actin metformin 1g twice a day (before dinner and before breakfast) with fasting glucose 200-270mg/dL
DRUGglimepirideglimepiride 2mg once a day with fasting glucose 130-199mg/dL, or glimepiride 2mg twice a day (before dinner and before breakfast) with fasting glucose 200-270mg/dL

Timeline

Start date
2009-02-01
Primary completion
2010-05-01
First posted
2009-07-17
Last updated
2010-05-18

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT00941161. Inclusion in this directory is not an endorsement.